Skip to main content
Clinical Trials/NL-OMON22954
NL-OMON22954
Recruiting
Not Applicable

Endoscopic drainage of presumed resectable perihilar cholangiocarcinoma using a novel design short fully covered self-expanding metal stent with retrieval string (CHORDA)

Amsterdam UMC0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
(Potentially) resectable perihilar cholanhiocarcinoma
Sponsor
Amsterdam UMC
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • 18 years or older.
  • \- Capable of providing written and oral informed consent.
  • \- Presumed perihilar cholangiocarcinoma.
  • \- Biliary obstruction in the future liver remnant.
  • \- Drainage naïve patients: total bilirubin \>50 umol/L
  • \- Patients with previous endobiliary drainage procedures: persistently rising total bilirubin \>50 umol/L (i.e. no stent placed or insufficient draining stent) or persistent biliary dilatation in the future liver remnant on imaging (i.e. previous stent placed in contralateral side of the liver).

Exclusion Criteria

  • \- Incompletely recovered from any side effects of previous biliary drainage procedures. Patients are required to be off antibiotic treatment for at least 5 days.
  • \- Any contra\-indication for major liver surgery (e.g. ECOG/WHO score 3 or higher).
  • \- Technical contra\-indications for endobiliary drainage (e.g. previous gastrojejunostomy).
  • \- Refusal to provide informed consent.
  • \- Requirement of multiple stents for adequate drainage of the future liver remnant (e.g. involvement of segmental bile ducts).
  • \- In case it is not feasible to prevent blockage of one or more large segmental branches.

Outcomes

Primary Outcomes

Not specified

Similar Trials